HIV 1 News and Research

RSS

KFF Health News' 'What the Health?': Federal health work in flux

Two months into the new administration, federal workers and contractors remain off-balance as the Trump administration ramps up its efforts to cancel jobs and programs — even as federal judges declare many of those efforts illegal and/or unconstitutional.

20 Mar 2025

Study reveals how B cells safeguard high-affinity antibodies

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating in hopes of generating the most effective antibodies.

19 Mar 2025

Electronic cigarettes may pose lower cardiovascular risks for people with HIV

Electronic cigarettes use may pose lower cardiovascular risks in people living with HIV compared to tobacco cigarette use, new UCLA-led research shows.

19 Mar 2025

Third International Health Regulations Emergency Committee meeting addresses mpox upsurge

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) regarding the upsurge of mpox 2024, held on Tuesday, 25 February 2025, from 12:00 to 17:00 CET.

18 Mar 2025

In the Thymus We Trust: ProTcell Therapy & the Future of Allogeneic Immunotherapy

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

From Hanson Wade Group - 7th Allogeneic Cell Therapies Summit 18 Mar 2025

Predicting HIV treatment nonadherence in adolescents with machine learning

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million people in the world living with HIV.

17 Mar 2025

Over 40,000 new gut microbes discovered in African populations

More than 40,000 previously unknown gut microbes in African populations could completely change how medicines work for millions of people, according to scientists.

14 Mar 2025

ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

13 Mar 2025

Study reveals an integrated care model for improving outcomes among people who inject drugs

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.

12 Mar 2025

Study links Doomsday Clock to mortality and mental health

Since 1947, the Bulletin of the Atomic Scientists (BAS) has used the metaphor of the Doomsday Clock as a means of communicating how close the human species is to self-imposed annihilation, represented as midnight.

12 Mar 2025

Dementia risk higher among adults with HIV in Malawi

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according to a new study by a team of US and Malawian researchers.

12 Mar 2025

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions.

12 Mar 2025

Gilead’s capsid revolution meets our capsid solutions: Sino Biological – Engineering the tools to outsmart HIV

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).

From Sino Biological Inc. 12 Mar 2025

Gaps in HPV cancer screening and prevention identified for people living with HIV

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.

12 Mar 2025

Study finds no link between Medicaid expansion and opioid misuse

A new study has found that extending state Medicaid coverage did not increase the likelihood of prescription opioid or benzodiazepine misuse among people who use drugs.

11 Mar 2025

MRNA vaccines, once a Trump boast, now face attacks from some in GOP

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

10 Mar 2025

WHO study sheds light on global maternal mortality crisis

Hemorrhage – severe heavy bleeding – and hypertensive disorders like preeclampsia are the leading causes of maternal deaths globally, according to a new study released today by the World Health Organization (WHO).

9 Mar 2025

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.

8 Mar 2025

Long-acting HIV injections show success in patients with struggles to take daily pills

UCSF researchers are the first to demonstrate that the approach works for the patients who need it the most.

6 Mar 2025

New antibody pair could defeat all SARS-CoV-2 variants

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep pace with evolving viruses.

6 Mar 2025

HIV 1 News and Research

KFF Health News' 'What the Health?': Federal health work in flux

Study reveals how B cells safeguard high-affinity antibodies

Electronic cigarettes may pose lower cardiovascular risks for people with HIV

Third International Health Regulations Emergency Committee meeting addresses mpox upsurge

In the Thymus We Trust: ProTcell Therapy & the Future of Allogeneic Immunotherapy

Predicting HIV treatment nonadherence in adolescents with machine learning

Over 40,000 new gut microbes discovered in African populations

ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV

Study reveals an integrated care model for improving outcomes among people who inject drugs

Study links Doomsday Clock to mortality and mental health

Dementia risk higher among adults with HIV in Malawi

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

Gilead’s capsid revolution meets our capsid solutions: Sino Biological – Engineering the tools to outsmart HIV

Gaps in HPV cancer screening and prevention identified for people living with HIV

Study finds no link between Medicaid expansion and opioid misuse

MRNA vaccines, once a Trump boast, now face attacks from some in GOP

WHO study sheds light on global maternal mortality crisis

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

Long-acting HIV injections show success in patients with struggles to take daily pills

New antibody pair could defeat all SARS-CoV-2 variants

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News